Literature DB >> 9579232

Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma.

F J Pomares1, R Cañas, J M Rodriguez, A M Hernandez, P Parrilla, F J Tebar.   

Abstract

OBJECTIVES: Phaeochromocytoma may be either sporadic or part of a familial cancer syndrome. We have investigated whether there are differences between sporadic and MEN 2A phaeochromocytomas.
DESIGN: A retrospective study. We analysed age at presentation, sex, mode of presentation, clinical data, laboratory and imaging techniques, treatment, pathology and follow-up. PATIENTS: Forty-six patients diagnosed with phaeochromocytoma between 1979 and 1995 (23 sporadic and 23 familial) at the Hospital Universitario Virgen de la Arrixaca (Murcia, Spain), a tertiary referral centre.
RESULTS: Mean age at presentation was 47 +/- 16 years for sporadic and 38 +/- 11 years for familial phaeochromocytoma (P < 0.05). The most common clinical feature and the presenting feature in cases of isolated phaeochromocytoma was hypertension. Of the MEN 2A patients, 52% were asymptomatic at diagnosis and only 35% presented with hypertension. Levels of adrenaline, noradrenaline, dopamine and metanephrines in a 24-hour urine connection confirmed the diagnosis in 95% of the isolated and 91% of the familial phaeochromocytomas. Computed tomography located 100% of the sporadic and 76% of the familial phaeochromocytomas (P < 0.02). All the MEN 2A phaeochromocytomas were bilateral compared with none of the sporadic phaeochromocytomas (P < 0.001). All the patients with familial phaeochromocytoma underwent bilateral adrenalectomy. The patients with sporadic phaeochromocytoma had the affected gland or the tumour, if extraadrenal, removed.
CONCLUSIONS: In comparing sporadic and MEN 2A phaeochromocytoma we found differences in age at presentation, mode of presentation, clinical data, duration of clinical features, imaging findings bilaterality and type of surgical treatment required.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579232     DOI: 10.1046/j.1365-2265.1998.3751208.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

Review 1.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  Cancer Genet       Date:  2012 Jan-Feb

Review 2.  Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.

Authors:  Susan Richter; Nan Qin; Karel Pacak; Graeme Eisenhofer
Journal:  Adv Pharmacol       Date:  2013

3.  Adrenalectomy for familial pheochromocytoma in the laparoscopic era.

Authors:  L Michael Brunt; Terry C Lairmore; Gerard M Doherty; Mary A Quasebarth; Mary DeBenedetti; Jeffrey F Moley
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

4.  Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location.

Authors:  Graeme Eisenhofer; Henri J Timmers; Jacques W M Lenders; Stefan R Bornstein; Oliver Tiebel; Massimo Mannelli; Kathryn S King; Cathy D Vocke; W Marston Linehan; Gennady Bratslavsky; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2010-12-08       Impact factor: 5.958

5.  Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.

Authors:  George N Zografos; George K Vasiliadis; Flora Zagouri; Chrysanthi Aggeli; Dimitris Korkolis; Sophia Vogiaki; Matina K Pagoni; Gregory Kaltsas; George Piaditis
Journal:  World J Surg Oncol       Date:  2010-03-10       Impact factor: 2.754

Review 6.  Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman.

Authors:  Andreas Weinhäusel; Annemarie Behmel; Bruce A J Ponder; Oskar A Haas; Bruno Niederle; Alois Gessl; Heinrich Vierhapper; Roswitha Pfragner
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 7.  10 rare tumors that warrant a genetics referral.

Authors:  Kimberly C Banks; Jessica J Moline; Monica L Marvin; Anna C Newlin; Kristen J Vogel
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

8.  Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening.

Authors:  Kathryn J Rowland; Rebecca D Chernock; Jeffrey F Moley
Journal:  J Surg Oncol       Date:  2013-07-19       Impact factor: 3.454

Review 9.  Multiple Endocrine Neoplasia: A Genetically Diverse Group of Familial Tumor Syndromes.

Authors:  M Cristina Pacheco
Journal:  J Pediatr Genet       Date:  2016-03-09

10.  Pheochromocytoma in MEN 2A syndrome. Study of 54 patients.

Authors:  Jose M Rodriguez; Maria Balsalobre; Jose L Ponce; Antonio Ríos; Nuria M Torregrosa; Javier Tebar; Pascual Parrilla
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.